(MVST) Microvast Holdings - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US59516C1062
Stock: Battery Cells, Modules, Packs, Components,
Total Rating 36
Risk 39
Buy Signal -1.18
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 99.9% |
| Relative Tail Risk | -18.2% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.80 |
| Alpha | 24.27 |
| Character TTM | |
|---|---|
| Beta | 1.328 |
| Beta Downside | 0.941 |
| Drawdowns 3y | |
|---|---|
| Max DD | 94.40% |
| CAGR/Max DD | 0.16 |
Description: MVST Microvast Holdings January 20, 2026
Microvast Holdings, Inc. (NASDAQ: MVST) designs, develops and manufactures lithium-ion battery components-including cathodes, anodes, electrolytes, separators and full-cell chemistries such as lithium-titanate oxide and lithium-iron-phosphate-and sells integrated battery packs for electric commercial vehicles and stationary energy-storage systems across North America, Europe, China and the broader Asia-Pacific region.
Key recent metrics show the company generated roughly $63 million of revenue in 2023 while maintaining a cash runway of over $200 million, reflecting its sizable order backlog of multi-gigawatt-hour contracts for electric buses and mining trucks in China. The EV market’s projected CAGR of 27 % through 2030 and the ongoing decline in battery pack prices (≈-9 % YoY) are primary macro drivers of demand for Microvast’s high-power, fast-charging chemistries.
For a deeper quantitative dive, the ValueRay platform provides granular financial and operational metrics on MVST that can help you assess its upside potential.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income: -151.2m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA 7.54 > 1.0 |
| NWC/Revenue: -19.05% < 20% (prev 29.34%; Δ -48.40% < -1%) |
| CFO/TA 0.06 > 3% & CFO 65.6m > Net Income -151.2m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 0.84 > 1.5 & < 3 |
| Outstanding Shares: last quarter (323.8m) vs 12m ago 1.00% < -2% |
| Gross Margin: 36.60% > 18% (prev 0.28%; Δ 3632 % > 0.5%) |
| Asset Turnover: 43.69% > 50% (prev 33.94%; Δ 9.75% > 0%) |
| Interest Coverage Ratio: -27.40 > 6 (EBITDA TTM -112.4m / Interest Expense TTM 5.29m) |
Altman Z'' -7.03
| A: -0.08 (Total Current Assets 445.3m - Total Current Liabilities 530.0m) / Total Assets 1.01b |
| B: -1.12 (Retained Earnings -1.14b / Total Assets 1.01b) |
| C: -0.14 (EBIT TTM -144.9m / Avg Total Assets 1.02b) |
| D: -1.77 (Book Value of Equity -1.16b / Total Liabilities 655.5m) |
| Altman-Z'' Score: -7.03 = D |
Beneish M -3.47
| DSRI: 0.96 (Receivables 149.3m/121.5m, Revenue 444.5m/346.5m) |
| GMI: 0.76 (GM 36.60% / 27.68%) |
| AQI: 0.72 (AQ_t 0.03 / AQ_t-1 0.04) |
| SGI: 1.28 (Revenue 444.5m / 346.5m) |
| TATA: -0.21 (NI -151.2m - CFO 65.6m) / TA 1.01b) |
| Beneish M-Score: -3.47 (Cap -4..+1) = AA |
What is the price of MVST shares?
As of February 07, 2026, the stock is trading at USD 2.39 with a total of 3,820,962 shares traded.
Over the past week, the price has changed by -10.49%, over one month by -24.37%, over three months by -54.91% and over the past year by +44.85%.
Over the past week, the price has changed by -10.49%, over one month by -24.37%, over three months by -54.91% and over the past year by +44.85%.
Is MVST a buy, sell or hold?
Microvast Holdings has received a consensus analysts rating of 4.00.
Therefore, it is recommended to buy MVST.
- StrongBuy: 1
- Buy: 1
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the MVST price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 6.5 | 172% |
| Analysts Target Price | 6.5 | 172% |
| ValueRay Target Price | 2.4 | -1.7% |
MVST Fundamental Data Overview February 02, 2026
P/E Forward = 40.6504
P/S = 1.9344
P/B = 2.4469
Revenue TTM = 444.5m USD
EBIT TTM = -144.9m USD
EBITDA TTM = -112.4m USD
Long Term Debt = 76.1m USD (from longTermDebt, last quarter)
Short Term Debt = 141.6m USD (from shortTermDebt, last quarter)
Debt = 156.7m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 65.9m USD (from netDebt column, last quarter)
Enterprise Value = 925.8m USD (859.8m + Debt 156.7m - CCE 90.7m)
Interest Coverage Ratio = -27.40 (Ebit TTM -144.9m / Interest Expense TTM 5.29m)
EV/FCF = 20.11x (Enterprise Value 925.8m / FCF TTM 46.0m)
FCF Yield = 4.97% (FCF TTM 46.0m / Enterprise Value 925.8m)
FCF Margin = 10.36% (FCF TTM 46.0m / Revenue TTM 444.5m)
Net Margin = -34.01% (Net Income TTM -151.2m / Revenue TTM 444.5m)
Gross Margin = 36.60% ((Revenue TTM 444.5m - Cost of Revenue TTM 281.8m) / Revenue TTM)
Gross Margin QoQ = 37.65% (prev 34.73%)
Tobins Q-Ratio = 0.91 (Enterprise Value 925.8m / Total Assets 1.01b)
Interest Expense / Debt = 0.80% (Interest Expense 1.25m / Debt 156.7m)
Taxrate = 21.0% (US default 21%)
NOPAT = -114.5m (EBIT -144.9m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 0.84 (Total Current Assets 445.3m / Total Current Liabilities 530.0m)
Debt / Equity = 0.44 (Debt 156.7m / totalStockholderEquity, last quarter 358.1m)
Debt / EBITDA = -0.59 (negative EBITDA) (Net Debt 65.9m / EBITDA -112.4m)
Debt / FCF = 1.43 (Net Debt 65.9m / FCF TTM 46.0m)
Total Stockholder Equity = 389.1m (last 4 quarters mean from totalStockholderEquity)
RoA = -14.86% (Net Income -151.2m / Total Assets 1.01b)
RoE = -38.86% (Net Income TTM -151.2m / Total Stockholder Equity 389.1m)
RoCE = -31.16% (EBIT -144.9m / Capital Employed (Equity 389.1m + L.T.Debt 76.1m))
RoIC = -15.57% (negative operating profit) (NOPAT -114.5m / Invested Capital 735.3m)
WACC = 9.24% (E(859.8m)/V(1.02b) * Re(10.81%) + D(156.7m)/V(1.02b) * Rd(0.80%) * (1-Tc(0.21)))
Discount Rate = 10.81% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 2.03%
[DCF Debug] Terminal Value 77.33% ; FCFF base≈46.0m ; Y1≈56.8m ; Y5≈96.7m
Fair Price DCF = 3.77 (EV 1.30b - Net Debt 65.9m = Equity 1.24b / Shares 328.2m; r=9.24% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 22.24 | EPS CAGR: 264.5% | SUE: 0.12 | # QB: 0
Revenue Correlation: 82.31 | Revenue CAGR: 19.15% | SUE: 0.28 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.05 | Chg30d=+0.010 | Revisions Net=+1 | Analysts=1
EPS next Year (2026-12-31): EPS=0.20 | Chg30d=-0.090 | Revisions Net=-1 | Growth EPS=+17.6% | Growth Revenue=+17.7%
P/S = 1.9344
P/B = 2.4469
Revenue TTM = 444.5m USD
EBIT TTM = -144.9m USD
EBITDA TTM = -112.4m USD
Long Term Debt = 76.1m USD (from longTermDebt, last quarter)
Short Term Debt = 141.6m USD (from shortTermDebt, last quarter)
Debt = 156.7m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 65.9m USD (from netDebt column, last quarter)
Enterprise Value = 925.8m USD (859.8m + Debt 156.7m - CCE 90.7m)
Interest Coverage Ratio = -27.40 (Ebit TTM -144.9m / Interest Expense TTM 5.29m)
EV/FCF = 20.11x (Enterprise Value 925.8m / FCF TTM 46.0m)
FCF Yield = 4.97% (FCF TTM 46.0m / Enterprise Value 925.8m)
FCF Margin = 10.36% (FCF TTM 46.0m / Revenue TTM 444.5m)
Net Margin = -34.01% (Net Income TTM -151.2m / Revenue TTM 444.5m)
Gross Margin = 36.60% ((Revenue TTM 444.5m - Cost of Revenue TTM 281.8m) / Revenue TTM)
Gross Margin QoQ = 37.65% (prev 34.73%)
Tobins Q-Ratio = 0.91 (Enterprise Value 925.8m / Total Assets 1.01b)
Interest Expense / Debt = 0.80% (Interest Expense 1.25m / Debt 156.7m)
Taxrate = 21.0% (US default 21%)
NOPAT = -114.5m (EBIT -144.9m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 0.84 (Total Current Assets 445.3m / Total Current Liabilities 530.0m)
Debt / Equity = 0.44 (Debt 156.7m / totalStockholderEquity, last quarter 358.1m)
Debt / EBITDA = -0.59 (negative EBITDA) (Net Debt 65.9m / EBITDA -112.4m)
Debt / FCF = 1.43 (Net Debt 65.9m / FCF TTM 46.0m)
Total Stockholder Equity = 389.1m (last 4 quarters mean from totalStockholderEquity)
RoA = -14.86% (Net Income -151.2m / Total Assets 1.01b)
RoE = -38.86% (Net Income TTM -151.2m / Total Stockholder Equity 389.1m)
RoCE = -31.16% (EBIT -144.9m / Capital Employed (Equity 389.1m + L.T.Debt 76.1m))
RoIC = -15.57% (negative operating profit) (NOPAT -114.5m / Invested Capital 735.3m)
WACC = 9.24% (E(859.8m)/V(1.02b) * Re(10.81%) + D(156.7m)/V(1.02b) * Rd(0.80%) * (1-Tc(0.21)))
Discount Rate = 10.81% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 2.03%
[DCF Debug] Terminal Value 77.33% ; FCFF base≈46.0m ; Y1≈56.8m ; Y5≈96.7m
Fair Price DCF = 3.77 (EV 1.30b - Net Debt 65.9m = Equity 1.24b / Shares 328.2m; r=9.24% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 22.24 | EPS CAGR: 264.5% | SUE: 0.12 | # QB: 0
Revenue Correlation: 82.31 | Revenue CAGR: 19.15% | SUE: 0.28 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.05 | Chg30d=+0.010 | Revisions Net=+1 | Analysts=1
EPS next Year (2026-12-31): EPS=0.20 | Chg30d=-0.090 | Revisions Net=-1 | Growth EPS=+17.6% | Growth Revenue=+17.7%